MBB Public Markets I LLC Buys New Position in Henry Schein, Inc. $HSIC

Key Points

• MBB Public Markets I LLC has acquired a new stake in Henry Schein, purchasing 4,500 shares valued at approximately $308,000 during the first quarter.
• Henry Schein reported earnings of $1.10 per share for the last quarter, falling short of analysts' expectations, while revenue increased by 3.3% year-over-year to $3.24 billion.
• The company's stock has seen recent analyst rating shifts, with five analysts giving a Buy rating and a consensus rating of "Hold" with an average target price of $76.67.

MBB Public Markets I LLC bought a new stake in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 4,500 shares of the company's stock, valued at approximately $308,000.

Other large investors also recently added to or reduced their stakes in the company. Investment Management Corp VA ADV bought a new stake in Henry Schein during the fourth quarter valued at approximately $32,000. Rakuten Securities Inc. bought a new stake in Henry Schein during the first quarter valued at approximately $34,000. Whittier Trust Co. grew its position in Henry Schein by 714.3% during the first quarter. Whittier Trust Co. now owns 798 shares of the company's stock valued at $55,000 after buying an additional 700 shares during the period. Quarry LP bought a new stake in Henry Schein during the first quarter valued at approximately $71,000. Finally, UMB Bank n.a. grew its position in Henry Schein by 23.2% during the first quarter. UMB Bank n.a. now owns 1,066 shares of the company's stock valued at $73,000 after buying an additional 201 shares during the period. 96.62% of the stock is currently owned by institutional investors.

Henry Schein Price Performance

Shares of NASDAQ:HSIC opened at $67.41 on Thursday. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.78 and a current ratio of 1.41. The firm has a fifty day moving average price of $69.54 and a 200 day moving average price of $69.59. Henry Schein, Inc. has a fifty-two week low of $60.56 and a fifty-two week high of $82.49. The firm has a market cap of $8.17 billion, a price-to-earnings ratio of 21.75, a P/E/G ratio of 2.23 and a beta of 0.86.

Henry Schein (NASDAQ:HSIC - Get Free Report) last issued its earnings results on Tuesday, August 5th. The company reported $1.10 earnings per share for the quarter, missing analysts' consensus estimates of $1.19 by ($0.09). Henry Schein had a return on equity of 14.36% and a net margin of 3.05%.The company had revenue of $3.24 billion for the quarter, compared to the consensus estimate of $3.22 billion. During the same quarter in the prior year, the company posted $1.23 EPS. Henry Schein's revenue was up 3.3% compared to the same quarter last year. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS. As a group, sell-side analysts expect that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on the stock. Wall Street Zen lowered shares of Henry Schein from a "buy" rating to a "hold" rating in a research report on Sunday. Leerink Partners set a $75.00 target price on shares of Henry Schein in a research note on Monday, July 14th. UBS Group lowered their target price on shares of Henry Schein from $75.00 to $70.00 and set a "neutral" rating on the stock in a research note on Wednesday, August 6th. Evercore ISI upgraded shares of Henry Schein from an "in-line" rating to an "outperform" rating and set a $83.00 target price on the stock in a research note on Tuesday, August 26th. Finally, JPMorgan Chase & Co. lowered their target price on shares of Henry Schein from $80.00 to $76.00 and set an "overweight" rating on the stock in a research note on Thursday, August 7th. Five research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of "Hold" and an average target price of $76.67.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.